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ABSTRACT 
Hyptis umbrosa (syn. Mesosphaerum sidifolium) (Lamiaceae Family) has been used to treat several conditions 
such as gastrointestinal disorders, skin infections, nasal congestion, fever and cramps. The objective of this study 
was to evaluate the chemical composition, analgesic and anti-inflammatory profiles of ethanol extract from 
leaves of Hyptis umbrosa (EEB). HPLC-DAD was used to determine the fingerprint chromatogram of the ex-
tract. Male Swiss mice were orally pretreated with EEB (100, 200 or 400 mg/kg; 60 min before initiating algesic 
stimulation) and antinociceptive activity was assessed using the acetic acid-induced writhing model, formalin 
test and hyperalgesia induced by glutamate or capsaicin. Also, peritonitis was induced by the intrathoracic injec-
tion of carrageenan to quantify the total number of leukocytes. The presence of phenolic compounds in the ex-
tract was confirmed using HPLC-DAD. The treatment with EEB, at all doses, produced a significant analgesic 
effect against acetic acid-induced antinociceptive activity. In the formalin test, only the 400-mg/kg-dose of EEB 
had a significant effect in the first phase. However, all doses tested were able to reverse nociception in the sec-
ond phase. The effect of all doses of EEB also showed a significant antinociceptive effect in the glutamate and 
capsaicin tests and inhibited the carrageenan-induced leukocyte migration to the peritoneal cavity. The present 
study suggests that the EEB possesses peripheral analgesic action and showed potential in reducing the spread-
ing of the inflammatory processes. Also, it seems to be related with vanilloid and glutamate receptors. 
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INTRODUCTION 
The species of Lamiaceae are composed 
of several species, such as Hyptis pectinata, 
Hyptis mutabilis, Hyptis fruticosa and Hyptis 
umbrosa. Such plants are frequently found 
on the northeastern Brazilian coast (Joly, 
1998). Plants of Hyptis species have great 
economical and ethnopharmacological im-
portance (Franco et al., 2011a). Under the 
chemical point of view, there are compounds 
belonging to classes of metabolites, the ace-
tate pathway, the shikimate pathway and also 
the compounds of mixed biosynthetic origin 
(Falcão and Menezes, 2003; Franco et al., 
2011a). 
It has been alleged that the Hyptis genus 
possesses medicinal properties and it is rec-
ommended in folk medicine for the treatment 
of several conditions, such as gastrointestinal 
disorders, skin infections, nasal congestion, 
fever and cramps (Rojas et al., 1992). Addi-
tionally, redox, analgesic and anti-
inflammatory profiles have been reported to 
this genus (Franco et al., 2011b; Lima et al., 
2013; Menezes et al., 2015; Paixão et al., 
2015, 2013).  
The Hyptis umbrosa is popularly known 
as “aleluia do serrote” (Silva and Andrade, 
2004) and “alfazema do mato” 
(Fernandes,2007). There are few reports in 
the literature on phytochemical and pharma-
cological studies of this species (Piozzi et al., 
2009). According to Matida et al. (1986), the 
presence of ursolic acid and 2α-hidroxy-
ursolic acid was already confirmed in the 
ethanolic extract from leaves of H. umbrosa.  
Fifty nine components of the essential oil 
from aerial parts of Hyptis umbrosa have al-
ready been identified through chromato-
graphic methods. Among the major compo-
nents found, terpenes were more highlighted, 
such as fenchone (24.8 %), cubebol (6.9 %) 
and limonene (5.4 %) (Rolim, 2013). Such 
data can contribute to a better understanding 
of the pharmacological effects of the extract 
under study since the terpenes have been de-
scribed for their analgesic and anti-
inflammatory properties, mainly to acute and 
inflammatory pains (Guimarães et al., 2013, 
2014; Quintans-Júnior et al., 2013; Quintans 
et al., 2014; Siqueira-Lima et al., 2014, 
2016, 2017). 
Due to the medicinal folk use of Hyptis 
umbrosa, mainly as tea, and lack of 
knowledge on its pharmacological proper-
ties, we evaluated antinociceptive and anti-
inflammatory effects of the ethanol extract 
from leaves of H. umbrosa (EEB) in experi-
mental protocols. 
 
MATERIAL AND METHODS 
Drugs and reagents 
The drugs and reagents used in this study 
were morphine sulphate (Dimorf-Cristália, 
Brazil), glutamate (Sigma, USA), capsaicin 
(Sigma, USA), λ-Carrageenan (Sigma, 
USA), naloxone (Res. Biochemicals Inc., 
USA), dexamethasone (União Química, Bra-
zil) and formaldehyde (Merck, USA). The 
vehicle was 0.2 % Tween 80 (Sigma, USA) 
dissolved in saline solution (NaCl 0.9 %). 
These chemical reference substances 
were used: caffeic acid, chlorogenic acid, 
gallic acid, p-coumaric acid, protocatechuic 
acid, tannic acid, apigenin, borneol, catechin, 
chrysin, epicatechin, epigallocatechin, 
fisetin, gallocatechin, kaempferol, lupeol, 
myricetin, narigenin, quercetin, quercetin 3-
β-glucoside, resveratrol, rutin and scopoletin 
(purity ≥ 97 %), which were obtained from 
Sigma Aldrich (USA). HPLC grade metha-
nol was acquired by Carlo Erba (France). 
Acetonitrile of HPLC grade was purchased 
from Merck (Germany). HPLC-grade tri-
fluoroacetic acid was obtained from Sigma 
(USA) with ultrapure water. 
 
Animals 
Experimental protocols were performed 
using male Swiss mice (25-30 g) obtained 
from the Animal Facilities of the Federal 
University of Sergipe (UFS). Mice were 
housed in controlled-temperature rooms (21 
± 2°C), under a 12 h light/dark cycle, with 
access to water and food ad libitum until use. 
Experimental protocols were approved by 
the Animal Care and Use Committee at 
UFS/Brazil (CEPA # 47/09). Nociceptive 
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and inflammatory tests were performed un-
der blind conditions and all efforts were 
made to minimize the number of animals 
used and their discomfort. 
 
Sample preparation  
The leaves of H. umbrosa were collected 
in the municipality of Matureia (7° 11′ 10′′ 
S, 37° 08′ 22′′ and 37° 25′ 53′′ W), State of 
Paraíba, in July 2009. The plant material was 
identified by Prof. Maria de Fátima Agra, 
Head of the Botany Section of the Pharma-
ceutical Technology Laboratory (Laboratório 
de Tecnologia Farmacêutica, LTF). A 
voucher specimen (AGRA 5541) is deposit-
ed at the Prof. Lauro Pires Xavier herbarium 
(JPB) of the Federal University of Paraíba. 
Dried leaves (2 kg) were exhaustively ex-
tracted with 95 % EtOH at room temperature 
for three days. The extract obtained was con-
centrated in a rotary evaporator under re-
duced pressure at 40° C, yielding 200.0 g of 
EEB. 
A solution of 1 mg/mL of the H. umbro-
sa extract was prepared with HPLC-grade 
methanol, which was sonicated until com-
plete solubilization. The solution was filtered 
through a membrane filter of 0.22 μM pore 
(Chromafil® Xtra, USA). 
 
HPLC conditions 
The chromatographic analyses were per-
formed on a HPLC from Shimadzu® with a 
diode array detector (DAD) and a C18 col-
umn with dimensions of 250 x 4.6 mm, 5 μm 
(Hypersil ThermoScientific®) with guard 
column, and the temperature was kept stable 
at 30° C throughout the analysis. Two solu-
tions were used as mobile phase: Solution A 
consisted of ultrapurified water + trifluoroa-
cetic acid 0.1 % (v/v) and B, acetonitrile so-
lution. Samples were analyzed using a gradi-
ent system described in the Table 1, with a 
0.6 mL.min-1 flow. 
The analytical standards and samples 
were injected in the volume of 30 μL and the 
detection was performed in DAD at a wave-
length of 270 nm. The software LCSolution 
1.0 (Shimadzu®, Japan) was used for the data 
analysis. 
 
Table 1: Gradient system used in the analysis 
through HPLC-DAD 
Gradient 
system 
Time in 
min 
Solution A 
(%) 
Solution B 
(%) 
Linear  
gradient 0-50 100 - 50 0 - 50 
Isocratic 50-60 50 50 
Linear  
gradient 60-70 50 - 100 50 - 0 
 
 
Pharmacological assessment 
Acetic acid-induced abdominal writhes 
Abdominal writhes consisted of a con-
traction of the abdominal muscle together 
with a stretching of the hind limbs, induced 
by intraperitoneal (i.p.) injection of acetic ac-
id (0.75 % solution, 0.1 mL/10 g) in mice, 
the algogen agent (Koster et al., 1959). The 
animals were previously treated via oral 
route (gavage, p.o.) with different doses of 
EEB (100, 200 or 400 mg/kg) 60 min before 
initiating algesic stimulation, or with mor-
phine (MOR, 5 mg/kg, as positive control), 
in the absence and presence of naloxone 
(NAL) (n = 8/per group). The control group 
received vehicle, saline + 0.2 % Tween 80 
(0.1 mL/10 g, p.o., 60 min beforehand, n = 8, 
per group). The abdominal writhes were reg-
istered, in separate individual chambers, for 
a period of 20 min (for each animal), starting 
after the administration of acetic acid. 
Formalin test 
The formalin test was applied according 
to the method of Hunskaar and Hole (1987). 
Mice were pre-treated with EEB (100, 200, 
or 400 mg/kg, p.o., 60 min beforehand), or 
with morphine (MOR, 5 mg/kg; i.p., 30 min 
beforehand), in the absence and presence of 
naloxone (NAL), before intraplantar injec-
tion of 1 % formalin solution (20 µL) into 
the right hind paw of the animal (n = 8 per 
group). The control group received vehicle, 
similar to the previous test (writhing test). 
The time during which the animal spent lick-
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ing or biting its paw was measured during 
the first-phase (0-5 min) and the second-
phase (15-30 min) of the test. 
Glutamate- and capsaicin-induced  
nociception 
The methods used were similar to that 
described previously (Quintans-Junior et al., 
2010). The mice were placed individually for 
5 min in a transparent plexiglass cage obser-
vation chamber (25 cm × 15 cm × 15 cm) as 
an adaptation period. After that, either 20 
μmol glutamate per paw or 20 μL of capsai-
cin (1.6 μg/paw prepared in a phosphate-
buffered solution) was injected under the 
skin of the dorsal surface on the right hind 
paw. The mice were pre-treated with EEB 
(100, 200, or 400 mg/kg, p.o.) or morphine 
(MOR, 5 mg/kg) 1 h before the injection of 
the irritant agent (glutamate or capsaicin). 
The control animals received a similar vehi-
cle of the early tests. The amount of time 
spent licking the injected paw was timed 
with a chronometer and was considered in-
dicative of nociception. 
Carrageenan-induced peritonitis 
Peritonitis was induced by the intratho-
racic (i.t.) injection of carrageenan (500 µg/ 
cavity, 500 µL, i.p) diluted in sterile saline. 
Control animals received the same volume of 
vehicle. The animals were pretreated with 
EEB (100, 200, or 400 mg/kg, p.o.), dexame-
thasone (2 mg/kg, s.c.) or vehicle (saline + 
0.2 % Tween 80, p.o.) 60 min before the in-
jection of carrageenan. Four hours after 
stimulation, the animals were sacrificed in a 
CO2 chamber; the pleural cavities were 
opened and washed with 1 mL of PBS (1×) 
containing EDTA (10 mM). Total leukocyte 
counts collected in the pleural lavage were 
performed on a Neubauer chamber under an 
optical microscope. The samples were dilut-
ed (40×) in Türk solution. 
 
Statistical analysis 
Values are expressed as mean ± SEM. 
The data obtained were evaluated through 
the one-way analysis of variance (ANOVA) 
followed by Tukey’s test. In all cases, differ-
ences were considered significant if p > 0.05. 
All statistical analyses were performed using 
the software GraphPad Prism 5.0 (GraphPad 
Prism Software Inc., San Diego, CA, USA). 
 
RESULTS 
HPLC Analysis 
In this study we developed a method 
based on HPLC-DAD in order to obtain a 
chromatographic system that was able to 
elute and provide good resolution in the sep-
aration of compounds in the H. umbrosa ex-
tract, as it can be seen in Figure 1. 
By analyzing the chromatographic pro-
file of the sample, one can observe the pres-
ence of a major compound at retention time 
38.25 min, which showed an absorption 
spectrum λ 206/318 (Figure 1) with 98 % pu-
rity. 
 
 
Figure 1: Chromatogram of H. umbrosa ethanol-
ic extract (270 nm) 
 
It was not possible to identify the sub-
stances present in the H. umbrosa extract 
through the comparison of retention time and 
maximum absorption spectra at the analyti-
cal standards (Table 2). Therefore, no simi-
larity to any of the evaluated analytical 
standards was found. These compounds are 
under investigation. 
 
 
 
 
 
EXCLI Journal 2017;16:14-24 – ISSN 1611-2156 
Received: October 10, 2016, accepted: December 12, 2016, published: January 02, 2017 
 
 
18 
Table 2: Results obtained after the analysis of 
the analytical standards 
Analytical  
standards 
Retention  
time 
(min) 
Absorption 
(λ) in nm 
Epigallocatechin 04.67 261/372 
Tanic acid 05.70 258 
Lupeol 05.98 268/297/327/353
Borneol 06.02 278/316/339/392
Gallic acid 06.04 251/365 
Gallocatechin 06.05 258/353 
Chlorogenic acid 06.18 298/324 
Protocatechuic 
acid 06.36 248/282 
Catechin 06.50 267 
Epicatechin 07.04 265 
Caffeic acid 28.14 223/293/332 
p-Coumaric acid 29.62 259/293 
Rutin 30.35 243/344 
Scopoletin 31.50 212/286/333 
Quercetin-3β- 
glucoside 32.51 242/343 
Myricetin 38.03 240/362 
Fisetin 38.46 234/350 
Resveratrol 40.39 293 
Quercetin 44.07 242/346 
Naringenin 47.16 259/293 
Apigenin 48.28 255/310/338 
Kaempferol 48.92 258/293/343 
Chrisin 58.33 210/258/279/300
 
 
Effect of EEB on the acetic-acid-induced 
writhing test in mice 
The results shown in Figure 2 demon-
strated that the pretreatment with EEB (100, 
200, or 400 mg/kg, p.o.) was capable of in-
hibiting the abdominal writhing induced by 
the intraperitoneal administration of the ace-
tic acid when compared with the control 
group (p < 0.05 or p < 0.01). Morphine (3 
mg/kg), an opioid agonist, was used as posi-
tive control group and significantly (p < 
0.001) suppressed the acetic acid-response.  
Pretreatment with NAL (1.5 mg/kg, i.p.), 
an opioid antagonist, was performed 0.5 h 
before treatment (i.p.) with EEB (400 mg/kg) 
or MOR (3 mg/kg) and it was observed that 
naloxone significantly (p < 0.001) inhibited 
the antinociceptive effect of the morphine. 
However, naloxone was incapable of revers-
ing the action of EEB (400 mg/kg) when 
compared with the control group (Figure 2). 
 
 
Figure 2: Effect of EEB of H. umbrosa on the 
acetic acid-induced writhing test in the absence 
and presence of naloxone in mice. Vehicle (con-
trol), EEB (100, 200 and 400 mg/kg) or morphine 
(MOR) were administered p.o. 1 h before acetic 
acid injection. Pre-treatment with naloxone (NAL, 
1.5 mg/kg, i.p.) was performed 0.5 h before 
treatment (i.p.) with EEB (400 mg/kg), or MOR (3 
mg/kg). Each column represents mean ± S.E.M. 
(n = 6, per group). *p < 0.05 or ***p < 0.001 ver-
sus control. ###p < 0.001 versus MOR group 
(ANOVA followed by Tukey’s test). 
 
 
Effect of EEB on the formalin-induced  
nociception in mice 
The pretreatment with EEB (100, 200, or 
400 mg/kg, p.o.) had significant effect (p < 
0.001) only at the highest dose during the 
first phase of the test (0-5 min), whereas dur-
ing the second phase (20-25 min), EEB 
caused a significant reduction in the licking 
time in all doses tested when compared to 
the control group (Figure 3). Morphine was 
capable to inhibit both phases of the pain 
stimulus (p < 0.001). 
 
Effect of EEB on the glutamate-induced 
nociception in mice 
The results of the nociception induced by 
the glutamate test are represented in Figure 
4. Pretreatment with EEB (100, 200, or 400 
mg/kg, p.o.), as well as MOR, significantly 
decreased the face-rubbing behavior com-
pared with the control group (p < 0.001). 
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Figure 3: Effects of EEB of H. umbrosa on the 
formalin-induced nociception in mice. Vehicle 
(control), EEB (100, 200 and 400 mg/kg) or mor-
phine (MOR) were administered p.o. 1 h before 
formalin injection. (A) Represents the first phase 
and (B) represents second phase of formalin-
induced nociception. Each column represents 
mean ± S.E.M. (n = 8, per group). *p < 0.01, ** 
p > 0.01 or ***p < 0.001 versus control (ANOVA 
followed by Tukey’s test). 
 
 
 
Figure 4: Effects of EEB of H. umbrosa on the 
glutamate-induced nociception in mice. Vehicle 
(control), EEB (100, 200 and 400 mg/kg) or mor-
phine (MOR) were administered p.o. 1 h before 
glutamate injection. Each column represents 
mean ± S.E.M. (n = 8, per group). ***p < 0.001 
versus control (ANOVA followed by Tukey’s 
test). 
Effect of EEB on the capsaicin-induced  
nociception in mice 
Figure 5 shows that EEB significantly 
(p < 0.01) reduced the face-rubbing behavior 
induced by the administration of capsaicin. 
Morphine also decreased significantly (p < 
0.001) the orofacial behavior compared with 
the control group. 
 
 
Figure 5: Effects of EEB of H. umbrosa on the 
capsaicin-induced nociception in mice. Vehicle 
(control), EEB (100, 200 and 400 mg/kg) or mor-
phine (MOR) were administered p.o. 1 h before 
capsaicin injection. Each column represents 
mean ± S.E.M. (n = 8, per group). **p < 0.01 or 
***p < 0.001 versus control (ANOVA followed by 
Tukey’s test). 
 
 
Effect of EEB on CG-induced peritonitis 
Figure 6 shows the inhibitory effect of all 
doses of EEB on CG-induced response (p < 
0.01 or p < 0.001). The results obtained with 
the control group support the effect of EEB 
since the vehicle presented no activity, and 
the control drug dexamethasone inhibited 
(p < 0.001) the carrageenan-induced leuko-
cyte migration to the peritoneal cavity. 
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Figure 6: Effect of EEB of H. umbrosa on leuko-
cyte migration into the peritoneal cavity induced 
by carrageenan in mice. Groups of rats were pre-
treated with vehicle (control), dexamethasone 
(Dexa, 2 mg/kg, s.c.) or EEB (100, 200 and 400 
mg/kg) 60 min before carrageenan (500 
µg/cavity, 500 µL, i.p.)-induced peritonitis. Cell 
counts were performed at the time 4 h after the 
injection of carrageenan. Each value represents 
the mean ± S.E.M. **p < 0.01 or ***p < 0.001 re-
lated to control group. ANOVA followed by Tuk-
ey’s test. 
 
 
DISCUSSION 
H. umbrosa is a medicinal plant used in 
the folk medicine of northeastern Brazil. 
However, little is known about its possible 
biological activities. Hence, this is the first 
report on the ethanol extract from leaves of 
H. umbrosa (EEB), by oral administration, 
as analgesic and anti-inflammatory agents 
using experimental protocols in mice.  
The acetic acid-induced writhing reaction 
in mice, described as a typical model for in-
flammatory pain, has long been used as a 
classic model for the assessment of analgesic 
or anti-inflammatory properties of new 
agents (Mohamad et al., 2010). Acetic-acid 
causes tissue damage and acts indirectly by 
inducing the release of chemical mediators 
such as substance P, bradykinins, prosta-
glandins especially PGI2 as well as pro-
inflammatory cytokines such as IL-1, IL-6, 
IL-8 and TNF-α which stimulate the noci-
ceptive neurons that are sensitive to non-
steroidal anti-inflammatory drugs (NSAIDs) 
and to opioids drugs (Collier et al., 1968; 
Kumazawa et al., 1996; Le Bars et al., 2001; 
Ulugol et al., 2006). 
The results of the present study showed 
that all doses of EEB (100, 200 and 400 mg/ 
kg) had a significant effect on reducing the 
number of writhes when compared to the 
control group. The genus Hyptis (Lamiaceae) 
is composed of several plant species and 
many of them have already presented activi-
ty in inhibiting the writhing induced by ace-
tic acid characterizing the peripheral effect 
of the genus. The administration of six geno-
types of volatile oils of H. pectinata signifi-
cantly reduced the number of writhes in-
duced by acetic acid in a range from 62.5 % 
to 84.8 % (Arrigoni-Blank et al., 2008). Sim-
ilarly, Bispo et al. (2001) demonstrated that 
the aqueous extract of H. pectinata exhibited 
the same effect of EEB when the dose of 200 
mg/kg showed maximal effect on the number 
of writhes, since no significant difference 
was observed between the doses of 200 and 
400 mg/kg. Providing further support of the 
antinociceptive potential of the genus, essen-
tial oil of the H. fruticosa also proved to 
have peripheral action in this model, inhibit-
ing 35.7 % of writhes in its highest dose 
(Menezes et al., 2007). 
In order to better evaluate the possible 
central action of EEB, the animals were pre-
treated with NAL (1.5 mg/kg, i.p.) 0.5 h be-
fore treatment (i.p.) with EEB (400 mg/kg) 
or MOR (3 mg/kg). The data suggest that 
NAL was able to antagonize the action of 
MOR (p < 0.001); however, it was unable to 
reverse the antinociceptive action of EEB.  
The analgesic mechanism of action of 
EEB can, probably, involve inhibition of the 
synthesis and/or release of inflammatory 
mediators which promote pain in the noci-
ceptive nervous terminations, similarly to the 
NSAIDs suggesting a peripheral analgesic 
action. However, this method shows good 
sensitivity but is non-specific, since 
NSAIDs, opioid analgesics and even tricy-
clic antidepressants may inhibit the nocicep-
tive response in this model (Dai et al., 2002; 
Franca et al., 2001; Gonzalez et al., 2001). 
Additionally, plants of other species, such as 
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H. pectinata, were able to show a possible 
opioid action when antagonized by nalox-
one; however, a more specific test (hot plate) 
was used, known to assess the central action 
of new drugs (Arrigoni-Blank et al., 2008; 
Lisboa et al., 2006). 
In an attempt to obtain further evidence 
about the analgesic effect of EEB, we per-
formed the formalin test in mice. The forma-
lin test is a widely used test which helps to 
elucidate the mechanism of action of the 
drug under study (Le Bars et al., 2001). This 
test involves two phases: the first phase 
(neurogenic phase) results essentially from 
the direct stimulation of nociceptors and the 
second phase (inflammatory phase) which is 
originated from peripheral mechanisms with 
the release of chemical mediators (serotonin, 
histamine, bradykinin and prostaglandins (Le 
Bars et al., 2001; Murray et al., 1988; 
Tjolsen et al., 1992). Furthermore, the two 
phases of this test are sensitive to opioid an-
algesics whereas NSAIDs seem to suppress 
only the second phase (Hunskaar and Hole, 
1987; Malmberg and Yaksh, 1992; Shibata 
et al., 1989). 
Now, we demonstrated that all doses of 
EBB tested significantly decreased the noci-
ceptive response of the second stage, where-
as only the highest dose was successful in 
the first phase of the test. Knowing that 
chemical mediators such as serotonin, hista-
mine, bradykinin, prostaglandins and nitric 
oxide are involved in the inflammatory phase 
of the test (Luccarini et al., 2006), we can 
confirm that this compound has an anti-
inflammatory effect further emphasizing its 
peripheral analgesic action. 
Recently, plants of the genus Hyptis such 
as H. pectinata have showed an improve-
ment in the analgesic and anti-inflammatory 
profile in the formalin test when complexed 
with β-cyclodextrin (Menezes et al., 2015). 
These results can be attributed to the oil ma-
jor component (E)-caryophyllene, a sesquit-
erpene that can exert analgesic profile 
through its capacity to modulate inflammato-
ry and neuropathic pain (Klauke et al., 2014; 
Quintans-Júnior et al., 2016). 
There is ample evidence that the excita-
tory amino acids are responsible for the 
transmission of sensory information originat-
ing in the periphery to the CNS. Moreover, it 
is well established that glutamate injection 
evoked pronounced nociceptive responses, 
which are mediated by the activation of cel-
lular mediators and activatation of glutamate 
receptors (e.g. NMDA) (Beirith et al., 2002). 
These processes combined with other pro-
inflammatory mediators and cytokines 
(TNF-α and IL-1β) act synergistically in 
neuronal excitability (Bernardino et al., 
2005; Millan, 1999). 
Pain signals induced by glutamate could 
be associated with peripheral, spinal and su-
praspinal influences through mediation by 
NMDA and non-NMDA receptors (Beirith et 
al., 2002). Since all doses of EEB exhibited 
an inhibition of the nociceptive behavior (p < 
0.001) on glutamate-induced nociception, it 
can be suggested that it interferes with the 
glutamatergic system.  
Capsaicin-induced pain model is used to 
test drugs with neurogenic origin (Sakurada 
et al., 2003). Capsaicin is sensitive to transi-
ent receptor potential vaniloid 1 (TRPV1) 
and plays an important role in pain transduc-
tion through the Ca+2 influx channels and re-
lease of neuropeptides (substance P), excita-
tory amino acids (glutamate and aspartate), 
nitric oxide and other pro-inflammatory sub-
stances from peripheral terminals (Honda et 
al., 2008; Pelissier et al., 2002; Vogt-Eisele 
et al., 2007). In this respect, our results 
showed that EEB was able to reduce behav-
ioral response of the capsaicin-induced noci-
ception (p < 0.01), suggesting a possible 
modulation of the compound in the TRPV1 
receptors. 
Considering that leukocyte migration is a 
dynamic process involving the activation and 
release of inflammatory cytokines and chem-
ical mediators that synergistically promote 
the excitability of nociceptors (Adams and 
Nash, 1996; Dray, 1995; Kasama et al., 
2005), we assessed the leukocyte migration 
through carrageenan-induced peritonitis and 
observed that the EEB had an inhibitory ef-
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fect on leukocyte migration further proving 
the activity of this compound in inflammato-
ry pain. 
 
CONCLUSIONS 
In conclusion, the present study suggests 
that the EEB possesses peripheral analgesic 
action possibly mediating the release of 
chemical agents and also showed potential in 
reducing the spreading of the inflammatory 
processes by acting in leukocyte migration. 
The mechanism of action exerted by EEB is 
currently under investigation, but it seems to 
be related with vanilloid and glutamate re-
ceptors. 
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